Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avicanna Inc (TSX: AVCN )

0.3400 +0.0050 (+1.49%)
Streaming Delayed Price Updated: 3:55 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,000
Open 0.3400
Bid (Size) 0.3350 (70)
Ask (Size) 0.3400 (45)
Prev. Close 0.3350
Today's Range 0.3250 - 0.3400
52wk Range 0.2000 - 0.6000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-2.86%
-2.86%
1 Month
-2.86%
-2.86%
3 Month
+23.64%
+23.64%
6 Month
-37.04%
-37.04%
1 Year
-27.66%
-27.66%

More News

Read More
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Via Benzinga
Topics Cannabis
Exposures Cannabis
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
From Virtual Investor Conferences
Via GlobeNewswire
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
Via Benzinga
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
Via Benzinga
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
Via Benzinga
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Avicanna Expands Medical Cannabis Brand RHO Phyto Into Caribbean Region With Export To Barbados
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna's CEO Touts Q3 As 'Most Successful Quarter To Date' As It Posts Record Results, Expands Into 12th International Market
Via Benzinga
Avicanna Colombia Gets Green Light To Ship Cannabis Flower & Biomass To Global Market
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Completes Export Of CBD Isolate And Full Spectrum CBD From Colombia To Chile
Via Benzinga
Avicanna Ships Its Feminized Cannabis Seeds To Peru And Argentina
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Avicanna Completes Registration And Commercial Export Of Pura Earth CBD Brand In Ecuador
Via Benzinga
Avicanna Reaches Brazil With Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Stock Down On Announcing $2.12M Raise Via Secured Term Loan Financing
Via Benzinga
Avicanna's Shares Jump On $3.2M Export Deal With Brazilian Pharmaceutical Company
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.